Summary and conclusions
Iron should not be prescribed to middle-aged men or older women with anaemia unless the possibility that the iron deficiency is caused by a gastrointestinal tumour has been considered. Thus the prescribing of iron to elderly people was investigated by studying four different prescription statistics and by reviewing records. Over one in 10 women aged over 65 were prescribed iron tablets. Men and women in the oldest age groups were prescribed iron most frequently. The 
Methods
We studied the prescribing of iron tablets to elderly people in five ways. (1) From a study of living conditions in Sweden performed by the National Central Bureau of Statistics we obtained the proportion of people who stated that they had taken iron tablets during the two weeks preceding the interview." (2) The Department of Drugs examined a random sample of 0-350o of the total number of prescriptions for the whole country and established the number of elderly people for wl{om iron had been ordered and bought.12 (3) From the 1976 prescription statistics from the county of Jamtland in Sweden we calculated the proportions of people in different age groups who had been ordered iron and bought it.13 (4) From the computerised prescription data from the pharmacy in Tierp, a rural health centre equipped for research, we calculated the proportions of people in different age groups who had been ordered iron and bought it in 1975. (5) We reviewed case records to see why iron was prescribed.
The record review (5) We also performed a pilot study of over-the-counter sales, in which 40 customers who bought iron during a two-week period answered some questions. had a plausible reason for iron deficiency other than a bleeding gastrointestinal tumour. Another 10 (9",) of the older patients may have been considered to be inoperable cases. Thus only 18 (17iT0) of the patients over 75 years and nine (19"O ) of those between 45 (men) or 55 (women) and 75 years who got prescriptions for iron tablets ought to have got them without further investigations for the source of the bleeding. Twenty-two (20" ) of the patients aged 75 years and older and 10 (21°,) of those aged under 75 years had anaemia or hyposideraemia that we did not believe was caused by iron deficiency. These patients had diseases that often cause so-called anaemia of chronic disease, such as rheumatoid arthritis, renal failure, myeloma, or pneumonia. Iron treatment is in general not considered to be effective in these types of anaemia
Results
From the records we could not find any reason for prescribing iron for 49 (45",,) of the patients aged over 75 and 18 (38" ) of those aged under 75. These patients could be divided into two subgroups: 18 had no anaemia according to the record, and we guessed that fatigue had been the indication for the iron prescription; and for 49 no laboratory data could be found, so that the same reason for prescribing iron could probably be assumed.
Results ofpharmacy ibquiry-Swedish sales data for 1977 showed that the pharmacies sold 938 000 packages of iron tablets: 85 000 to hospitals, 597 000 on prescription, and 256 000 (300' ) over the counter. Of the customers who answered our questions, one-quarter said that they had previously been ordered to take iron and one-half that they were tired and considered iron to be strengthening.
Discussion
The proportions of middle-aged and old people prescribed iron tablets, which were derived from four different sets of statistics, were all high. In middle-aged men the proportion with prescriptions for iron tablets was five times the proportion estimated to have iron deficiency (10). 16 Only 27 (17 0) of the records examined contained the reason for prescribing iron. The results given here are our interpretations of the records. In each case there may have been reasons known to the prescribing doctor, based on personal knowledge of the patient, that were not in the record. We did not discuss each case with the prescribing doctor, but a joint discussion of our results elicited no reason for the prescriptions other than the ones mentioned.
If we assume that patients with gastrointestinal tumours are prescribed iron as often as people without, we can estimate that, among the about 185 000 middle-aged and elderly people in Sweden (men over 45 and women over 55) who are prescribed iron every year, there are about 150 men and 300 women with gastrointestinal malignancies." 1 Therefore, any prescribing information about iron tablets should emphasise that iron should be prescribed, particularly to elderly people, only after the doctor has considered the possibility that a bleeding gastrointestinal tumour may be present.
